Barclays
ZLAB icon

Barclays’s Zai Lab ZLAB Stock Holding History

Barclays’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55K Sell
292
-3,239
-92% -$64K ﹤0.01% 4766
2026
Q1 		$66.4K Buy
3,531
+3,530
+353,000% +$65.4K ﹤0.01% 4199
2025
Q4 		$18 Sell
1
-734
-100% -$17.2K ﹤0.01% 5150
2025
Q3 		$24.9K Sell
735
-6,803
-90% -$234K ﹤0.01% 4907
2025
Q2 		$264K Buy
7,538
+2,836
+60% +$93.2K ﹤0.01% 4112
2025
Q1 		$170K Buy
4,702
+1,000
+27% +$30.8K ﹤0.01% 4144
2024
Q4 		$97K Buy
3,702
+2,856
+338% +$79.3K ﹤0.01% 4599
2024
Q3 		$20.4K Sell
846
-4,172
-83% -$78.8K ﹤0.01% 4897
2024
Q2 		$87K Sell
5,018
-26,268
-84% -$462K ﹤0.01% 3972
2024
Q1 		$501K Buy
31,286
+30,686
+5,114% +$646K ﹤0.01% 3592
2023
Q4 		$16.4K Hold
600
– – ﹤0.01% 4927
2023
Q3 		$14.6K Hold
600
– – ﹤0.01% 4236
2023
Q2 		$16.6K Sell
600
-71,947
-99% -$2.35M ﹤0.01% 4163
2023
Q1 		$2.41M Buy
72,547
+18,147
+33% +$696K ﹤0.01% 2050
2022
Q4 		$1.67M Sell
54,400
-93,632
-63% -$2.95M ﹤0.01% 2383
2022
Q3 		$5.06M Sell
148,032
-114,384
-44% -$4.89M 0.01% 1154
2022
Q2 		$9.1M Buy
262,416
+127,930
+95% +$4.51M 0.01% 1052
2022
Q1 		$5.91M Buy
+134,486
New +$6.5M ﹤0.01% 1154
2020
Q3 		– Sell
-21,129
Closed -$1.74M – 5643
2020
Q2 		$1.74M Buy
21,129
+13,029
+161% +$881K ﹤0.01% 2256
2020
Q1 		$417K Buy
8,100
+4,605
+132% +$240K ﹤0.01% 3737
2019
Q4 		$145K Sell
3,495
-556
-14% -$20.5K ﹤0.01% 5258
2019
Q3 		$131K Buy
4,051
+3,372
+497% +$116K ﹤0.01% 5276
2019
Q2 		$23K Buy
+679
New +$20K ﹤0.01% 6385
2019
Q1 		– Sell
-2,790
Closed -$65K – 7379
2018
Q4 		$65K Buy
+2,790
New +$51.7K ﹤0.01% 5326

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Barclays's ZLAB Position: Q2 2026 in Review

Barclays reduced its Zai Lab (ZLAB) stake by 92% in Q2 2026, selling an estimated $64K and leaving 292 shares worth $5.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4766.

Barclays first reported a position in ZLAB in Q4 2018 and has held it in 24 quarters since. The position peaked at $9.1M in Q2 2022. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Barclays held 292 shares of Zai Lab worth $5.55K as of Q2 2026.
  • Barclays sold 3,239 Zai Lab shares in Q2 2026, an estimated $64K.
  • Zai Lab made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4766 holding.
  • Barclays first reported a position in Zai Lab in Q4 2018 and has held it in 24 quarters since.
  • Barclays's Zai Lab position peaked at $9.1M in Q2 2022.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.